Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection

Chi Xu; Vincent Wong; Ariefandi Kurniawan; Scott Wilson; Basu Gopal; Paul D. Lawton

doi:10.1111/imj.16178

Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection

Chi Xu, Vincent Wong, Ariefandi Kurniawan, Scott Wilson, Basu Gopal, Paul D. Lawton

Menzies School of Health Research

Research output: Contribution to journal › Letter › peer-review

Abstract

[No abstract]

Original language	English
Pages (from-to)	1506-1508
Number of pages	3
Journal	Internal Medicine Journal
Volume	53
Issue number	8
DOIs	https://doi.org/10.1111/imj.16178
Publication status	Published - Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/imj.16178

Cite this

@article{9ca57143dcb2486fa1831fd0bc5a9a58,

title = "Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection",

abstract = "[No abstract]",

author = "Chi Xu and Vincent Wong and Ariefandi Kurniawan and Scott Wilson and Basu Gopal and Lawton, {Paul D.}",

year = "2023",

month = aug,

doi = "10.1111/imj.16178",

language = "English",

volume = "53",

pages = "1506--1508",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection

AU - Xu, Chi

AU - Wong, Vincent

AU - Kurniawan, Ariefandi

AU - Wilson, Scott

AU - Gopal, Basu

AU - Lawton, Paul D.

PY - 2023/8

Y1 - 2023/8

N2 - [No abstract]

AB - [No abstract]

UR - http://www.scopus.com/inward/record.url?scp=85168428189&partnerID=8YFLogxK

U2 - 10.1111/imj.16178

DO - 10.1111/imj.16178

M3 - Letter

C2 - 37599228

AN - SCOPUS:85168428189

SN - 1444-0903

VL - 53

SP - 1506

EP - 1508

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 8

ER -

Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this